PCDHB13: A Potential Drug Target for Various Diseases (G56123)

Target Name: PCDHB13

NCBI ID: G56123

PCDHB13

PCDHB13: A Potential Drug Target for Various Diseases

PCDHB13 (Peripheral Connective Tissue-Specific Hexonucleotide) is a protein that is expressed in various tissues throughout the body, including connective tissue, nerve, and muscle cells. It is a key regulator of cell growth, differentiation, and survival, and is involved in the development and maintenance of tissues.

Recent studies have identified PCDHB13 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique expression pattern and functions in different tissues make it an attractive target for small molecule inhibitors.

PCDHB13 is a member of the hexonucleotide family, which includes a variety of proteins that play important roles in various cellular processes. It is expressed in various tissues throughout the body, including connective tissue, nerve, and muscle cells. In the brain, PCDHB13 is expressed in the glial cells, which are responsible for supporting and nourishing nerve cells. It is also expressed in the perceptual cortical cortical regions, which are involved in sensory processing.

PCDHB13 is a key regulator of cell growth, differentiation, and survival. It plays a role in the development and maintenance of tissues, and is involved in the regulation of cell proliferation, differentiation, and apoptosis. Its expression is regulated by various factors, including Wnt, TGF-β, and Notch signaling pathways.

In addition to its role in cell growth and differentiation, PCDHB13 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell survival by promoting the expression of anti-apoptotic genes, such as Bcl-2 and p53. Additionally, it has been shown to play a role in the regulation of cell survival by blocking the activity of pro-apoptotic enzymes, such as caspase-3 and Exec锟?.

PCDHB13 is also involved in the regulation of tissue homeostasis. It plays a role in the regulation of cell migration and in the maintenance of tissue structure and integrity. Its expression is regulated by various factors, including the Wnt signaling pathway.

In conclusion, PCDHB13 is a protein that is expressed in various tissues throughout the body and plays a critical role in the development and maintenance of tissues. Its unique expression pattern and functions in different tissues make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of PCDHB13 in various biological processes and to identify potential drug targets.

Protein Name: Protocadherin Beta 13

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHB13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHB13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets